12-50086152-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_003076.5(SMARCD1):c.178-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0144 in 1,530,350 control chromosomes in the GnomAD database, including 871 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.037 ( 256 hom., cov: 31)
Exomes 𝑓: 0.012 ( 615 hom. )
Consequence
SMARCD1
NM_003076.5 intron
NM_003076.5 intron
Scores
2
Splicing: ADA: 0.00001052
2
Clinical Significance
Conservation
PhyloP100: 0.171
Genes affected
SMARCD1 (HGNC:11106): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1) The protein encoded by this gene is a member of the SWI/SNF family of proteins, whose members display helicase and ATPase activities and which are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI and has sequence similarity to the yeast Swp73 protein. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 12-50086152-C-T is Benign according to our data. Variant chr12-50086152-C-T is described in ClinVar as [Benign]. Clinvar id is 1283034.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0915 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0374 AC: 5681AN: 152078Hom.: 251 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
5681
AN:
152078
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0330 AC: 6506AN: 197228 AF XY: 0.0291 show subpopulations
GnomAD2 exomes
AF:
AC:
6506
AN:
197228
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0118 AC: 16313AN: 1378154Hom.: 615 Cov.: 31 AF XY: 0.0123 AC XY: 8352AN XY: 676982 show subpopulations
GnomAD4 exome
AF:
AC:
16313
AN:
1378154
Hom.:
Cov.:
31
AF XY:
AC XY:
8352
AN XY:
676982
Gnomad4 AFR exome
AF:
AC:
2960
AN:
30950
Gnomad4 AMR exome
AF:
AC:
3452
AN:
33212
Gnomad4 ASJ exome
AF:
AC:
164
AN:
21042
Gnomad4 EAS exome
AF:
AC:
2810
AN:
38822
Gnomad4 SAS exome
AF:
AC:
3351
AN:
74432
Gnomad4 FIN exome
AF:
AC:
45
AN:
50488
Gnomad4 NFE exome
AF:
AC:
2429
AN:
1067254
Gnomad4 Remaining exome
AF:
AC:
982
AN:
56578
Heterozygous variant carriers
0
742
1484
2226
2968
3710
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0374 AC: 5689AN: 152196Hom.: 256 Cov.: 31 AF XY: 0.0381 AC XY: 2834AN XY: 74418 show subpopulations
GnomAD4 genome
AF:
AC:
5689
AN:
152196
Hom.:
Cov.:
31
AF XY:
AC XY:
2834
AN XY:
74418
Gnomad4 AFR
AF:
AC:
0.0939127
AN:
0.0939127
Gnomad4 AMR
AF:
AC:
0.0641746
AN:
0.0641746
Gnomad4 ASJ
AF:
AC:
0.00951557
AN:
0.00951557
Gnomad4 EAS
AF:
AC:
0.0545033
AN:
0.0545033
Gnomad4 SAS
AF:
AC:
0.0450207
AN:
0.0450207
Gnomad4 FIN
AF:
AC:
0.00103695
AN:
0.00103695
Gnomad4 NFE
AF:
AC:
0.00277884
AN:
0.00277884
Gnomad4 OTH
AF:
AC:
0.03463
AN:
0.03463
Heterozygous variant carriers
0
261
523
784
1046
1307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
168
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Coffin-Siris syndrome 11 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at